{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-22-000197","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2022-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.531891+00:00","generated_at":"2026-06-21T08:35:04.543433+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeoGenomics appoints Jeffrey S. Sherman as CFO; William Bonello steps down","bullets":["Jeffrey S. Sherman named CFO effective Dec 7, 2022; William Bonello remains as employee for transition support.","Base salary $525,000; annual target bonus 70% of salary; sign-on cash $250,000; sign-on equity $3,000,000 (RSUs and options).","Sherman has 32 years healthcare finance experience, previously CFO at Privia Health, HMS, AccentCare, Lifepoint Hospitals.","Sherman led the sale of HMS to Veritas-backed Gainwell Technologies for $3.4 billion in April 2021.","CEO Chris Smith highlights Sherman's skills in pricing, revenue cycle management to return NeoGenomics to profitable growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-22-000197","json":"https://secwatch.observer/filing/0001077183-22-000197.json","markdown":"https://secwatch.observer/filing/0001077183-22-000197.md","text":"https://secwatch.observer/filing/0001077183-22-000197.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/0001077183-22-000197-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/neo-20221205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:35:04.543433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f41803919","claim":"Jeffrey S. Sherman was appointed as Chief Financial Officer at NEOGENOMICS INC.","evidence_excerpt":"On December 5, 2022, the Company appointed Jeffrey S. Sherman, age 57, as Chief Financial Officer of the Company, effective December 7, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/0001077183-22-000197-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}